Discontinued ProductUnfortunately 1-[1-(2-Benzo[b]thienyl)cyclohexyl]pyrrolidine fumarate (Cat. No. 0720) has been withdrawn from sale for commercial reasons.
High affinity dopamine uptake inhibitor with selectivity for sites labelled with [3H]-cocaine.
|Storage||Desiccate at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Preparing Stock Solutions
The following data is based on the product molecular weight 401.52. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||2.49 mL||12.45 mL||24.91 mL|
|5 mM||0.5 mL||2.49 mL||4.98 mL|
|10 mM||0.25 mL||1.25 mL||2.49 mL|
|50 mM||0.05 mL||0.25 mL||0.5 mL|
References are publications that support the products' biological activity.
He et al (1993) Synthesis and biological evaluation of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine homologues at dopamine-uptake and phencyclidine and σ-binding sites. J.Med.Chem. 36 1188 PMID: 8098066
View Related Products by Product Action
Keywords: 1-[1-(2-Benzo[b]thienyl)cyclohexyl]pyrrolidine fumarate, supplier, Dopamine, Transporters, Dopamine, Transporters, Tocris Bioscience
Citations for 1-[1-(2-Benzo[b]thienyl)cyclohexyl]pyrrolidine fumarate
Citations are publications that use Tocris products.
Currently there are no citations for 1-[1-(2-Benzo[b]thienyl)cyclohexyl]pyrrolidine fumarate.
Reviews for 1-[1-(2-Benzo[b]thienyl)cyclohexyl]pyrrolidine fumarate
There are currently no reviews for this product. Be the first to review 1-[1-(2-Benzo[b]thienyl)cyclohexyl]pyrrolidine fumarate and earn rewards!
Have you used 1-[1-(2-Benzo[b]thienyl)cyclohexyl]pyrrolidine fumarate?
Submit a review and receive an Amazon gift card.
$10US/$10CAN/€7/£6 gift card for a review without an image
$25US/$25CAN/€18/£15 gift card for a review with an image
*Offer only valid in the USA / Canada, UK and EuropeSubmit a Review
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Dopamine Receptors Scientific Review
Written by Phillip Strange and revised by Kim Neve in 2013, this review summarizes the history of the dopamine receptors and provides an overview of individual receptor subtype properties, their distribution and identifies ligands which act at each receptor subtype. Compounds available from Tocris are listed.
The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.